The global clinical risk grouping solution market is estimated to be USD 0.803 billion in 2024 and is expected to reach USD 3.13 billion by 2035, with a CAGR of 13.16% during the forecast period 2025-2035. The market will grow as a result of factors such as a growing emphasis on value-based care, the need for population health management, the prevalence of chronic diseases, the growing use of AI and machine learning, and government initiatives and regulatory support.
As healthcare systems increasingly grapple with the management of large populations, particularly with an aging demographic, the demand for population health management (PHM) solutions continues to rise. For instance, on October 31, 2024, Loftware, a global leader in Enterprise Labeling and Artwork Management solutions, announced the general availability of its integrated solution in collaboration with Signant Health. This new offering seamlessly connects the Loftware Cloud Clinical Trials platform with Signant Health's GxP Inventory Clinical Supplies Management application. This integration exemplifies the innovative approaches being developed to enhance clinical risk grouping and improve population health outcomes.
By product, the software segment accounted for the highest revenue-grossing segment in the global clinical risk grouping solution market in 2024 owing to the increasing adoption of advanced healthcare IT systems, enhanced data analytics capabilities, and the need for efficient risk stratification in patient care. For instance, in November 2024, Affidea, the leading pan-European provider of community-based polyclinics, advanced diagnostics, and specialist services, is pleased to announce a strategic long-term collaboration with Reset Health to implement Roczen, a doctor-led, digital care model designed to treat and manage obesity and type 2 diabetes. Additionally, the services segment is predicted to grow at the fastest CAGR during the forecast period owing to the rising demand for implementation, training, and maintenance services to support the effective utilization of clinical risk grouping software.
By application, the population health management (PHM) segment accounted for the highest revenue-grossing segment in the global clinical risk grouping solution market in 2024 owing to the growing focus on value-based care models, which emphasize improving outcomes for large patient populations through targeted interventions. For instance, in September 2024, Cognition Corporation®, a leading provider of product development and compliance solutions for the life sciences industry, unveiled Compass MED, a ground-breaking solution set designed to streamline and improve the medical device development process. The company, whose customers include Boston Scientific, Smith+Nephew, Zimmer Biomet, and Cook Medical, created Compass MED in direct response to the market's need to manage the increasing complexity of medical device development. Additionally, the chronic disease management segment is predicted to grow at the fastest CAGR during the forecast period owing to its critical role in identifying high-risk patients and enabling proactive care management to reduce complications and healthcare costs.
By end-user, the hospital & clinics segment accounted for the highest revenue-grossing segment in the global clinical risk grouping solution market in 2024 owing to the widespread adoption of risk assessment tools to enhance patient safety, optimize treatment plans, and reduce readmissions. For instance, in September 2024, Sapiens International Corporation, a leading global provider of software solutions for the insurance industry, announced today that South Africa's Hollard Group Risk (HGR), a division of Hollard Life Insurance Company Limited, has gone live with Sapiens DataSuite to accelerate the complex migration of HGR's business and align processes with Sapiens CoreSuite for Life and Pensions. DataSuite will help with the transfer between the main system and HGR's legacy system. Additionally, the long-term care centers segment is predicted to grow at the fastest CAGR during the forecast period owing to the increasing need for efficient patient management and risk stratification among aging populations and patients with chronic conditions.
North American region is anticipated to have the highest revenue share during the forecast period owing to the early adoption of advanced healthcare technologies, strong presence of key market players, and increasing focus on value-based care initiatives. Additionally, the Asia Pacific region is predicted to grow at the fastest CAGR during the forecast period owing to the rising healthcare expenditure, growing prevalence of chronic diseases, and increasing adoption of digital health solutions driven by supportive government initiatives. For instance, in September 2024, Toshiba Digital Solutions Corporation (Toshiba), a company within the Toshiba Group that specializes in digital and quantum technology, and its strategic partner SpeQtral, a prominent provider of quantum communications technology, announced that they had signed a memorandum of understanding (MOU) with ST Engineering, a global technology, defense, and engineering group, to strengthen their go-to-market strategy for quantum.
This comprehensive research report focuses on the global and regional market size and forecasts from 2024 to 2035.
As healthcare systems increasingly grapple with the management of large populations, particularly with an aging demographic, the demand for population health management (PHM) solutions continues to rise. For instance, on October 31, 2024, Loftware, a global leader in Enterprise Labeling and Artwork Management solutions, announced the general availability of its integrated solution in collaboration with Signant Health. This new offering seamlessly connects the Loftware Cloud Clinical Trials platform with Signant Health's GxP Inventory Clinical Supplies Management application. This integration exemplifies the innovative approaches being developed to enhance clinical risk grouping and improve population health outcomes.
By product, the software segment accounted for the highest revenue-grossing segment in the global clinical risk grouping solution market in 2024 owing to the increasing adoption of advanced healthcare IT systems, enhanced data analytics capabilities, and the need for efficient risk stratification in patient care. For instance, in November 2024, Affidea, the leading pan-European provider of community-based polyclinics, advanced diagnostics, and specialist services, is pleased to announce a strategic long-term collaboration with Reset Health to implement Roczen, a doctor-led, digital care model designed to treat and manage obesity and type 2 diabetes. Additionally, the services segment is predicted to grow at the fastest CAGR during the forecast period owing to the rising demand for implementation, training, and maintenance services to support the effective utilization of clinical risk grouping software.
By application, the population health management (PHM) segment accounted for the highest revenue-grossing segment in the global clinical risk grouping solution market in 2024 owing to the growing focus on value-based care models, which emphasize improving outcomes for large patient populations through targeted interventions. For instance, in September 2024, Cognition Corporation®, a leading provider of product development and compliance solutions for the life sciences industry, unveiled Compass MED, a ground-breaking solution set designed to streamline and improve the medical device development process. The company, whose customers include Boston Scientific, Smith+Nephew, Zimmer Biomet, and Cook Medical, created Compass MED in direct response to the market's need to manage the increasing complexity of medical device development. Additionally, the chronic disease management segment is predicted to grow at the fastest CAGR during the forecast period owing to its critical role in identifying high-risk patients and enabling proactive care management to reduce complications and healthcare costs.
By end-user, the hospital & clinics segment accounted for the highest revenue-grossing segment in the global clinical risk grouping solution market in 2024 owing to the widespread adoption of risk assessment tools to enhance patient safety, optimize treatment plans, and reduce readmissions. For instance, in September 2024, Sapiens International Corporation, a leading global provider of software solutions for the insurance industry, announced today that South Africa's Hollard Group Risk (HGR), a division of Hollard Life Insurance Company Limited, has gone live with Sapiens DataSuite to accelerate the complex migration of HGR's business and align processes with Sapiens CoreSuite for Life and Pensions. DataSuite will help with the transfer between the main system and HGR's legacy system. Additionally, the long-term care centers segment is predicted to grow at the fastest CAGR during the forecast period owing to the increasing need for efficient patient management and risk stratification among aging populations and patients with chronic conditions.
North American region is anticipated to have the highest revenue share during the forecast period owing to the early adoption of advanced healthcare technologies, strong presence of key market players, and increasing focus on value-based care initiatives. Additionally, the Asia Pacific region is predicted to grow at the fastest CAGR during the forecast period owing to the rising healthcare expenditure, growing prevalence of chronic diseases, and increasing adoption of digital health solutions driven by supportive government initiatives. For instance, in September 2024, Toshiba Digital Solutions Corporation (Toshiba), a company within the Toshiba Group that specializes in digital and quantum technology, and its strategic partner SpeQtral, a prominent provider of quantum communications technology, announced that they had signed a memorandum of understanding (MOU) with ST Engineering, a global technology, defense, and engineering group, to strengthen their go-to-market strategy for quantum.
This comprehensive research report focuses on the global and regional market size and forecasts from 2024 to 2035.
Report Scope:
- Base Year: 2024
- Forecast Period: 2025-2035
- Study Coverage
- Market Forecast by Product, Application, and End-User
- Market Forecast for 5 Regions and 17+ Countries
- North America (U.S. and Canada)
- Europe (Germany, France, UK, Spain, Italy, Russia, Rest of Europe)
- Asia Pacific (China, Japan, India, Australia, South Korea, Rest of APAC)
- Latin America (Brazil, Mexico, Argentina, Rest of LATAM)
- MEA (South Africa, GCC, Rest of MEA)
- Exhaustive Company Profiles of the Top 10+ Major Market Players
- 20% Free Customization Available to Meet Your Exact Requirement.
Segmentation: Clinical Risk Grouping Solution Market Report 2024 - 2035
Clinical Risk Grouping Solution Market Analysis & Forecast by Product 2024 - 2035 (Revenue USD Bn)
- Software
- Services
Clinical Risk Grouping Solution Market Analysis & Forecast by Application 2024 - 2035 (Revenue USD Bn)
- Population Health Management
- Chronic Disease Management
- Clinical Decision Support
- Fraud Detection and Prevention
- Other
Clinical Risk Grouping Solution Market Analysis & Forecast by End-User 2024 - 2035 (Revenue USD Bn)
- Hospitals & Clinics
- Ambulatory Surgical Centers
- Long Term Care Centers
- Others
Clinical Risk Grouping Solution Market Analysis & Forecast by Region 2024 - 2035 (Revenue USD Bn)
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- UK
- Spain
- Italy
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of APAC
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of LATAM
- Middle East & Africa
- South Africa
- GCC
- Rest of MEA
Table of Contents
1. Research Methodology
2. Introduction
4. Market Environment Analysis
5. Market Dynamics
7. Clinical Risk Grouping Solution Market: Product Estimates & Trend Analysis
8. Clinical Risk Grouping Solution Market: Application Estimates & Trend Analysis
9. Clinical Risk Grouping Solution Market: End-User Estimates & Trend Analysis
10. Regional Market Analysis
11. North America Clinical Risk Grouping Solution Market
12. Europe Global Clinical Risk Grouping Solution Market
13. Asia Pacific Global Clinical Risk Grouping Solution Market
14. Latin America Global Clinical Risk Grouping Solution Market
15. MEA Global Clinical Risk Grouping Solution Market
16. Competitor Analysis
17. Company Profiles
Companies Mentioned
- Optum, Inc. (UnitedHealth Group)
- Cerner Corporation
- 3M Health Information Systems
- IBM Watson Health
- Change Healthcare
- Conduent, Inc.
- Health Catalyst, Inc.
- Nuance Communications (part of Microsoft)
- Inovalon Holdings, Inc.
- Allscripts Healthcare Solutions
- McKesson Corporation
- Cognizant Technology Solutions
- Philips Healthcare
- Oracle Cerner
- Epic Systems Corporation
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 200 |
| Published | December 2024 |
| Forecast Period | 2023 - 2034 |
| Estimated Market Value ( USD | $ 0.8 Billion |
| Forecasted Market Value ( USD | $ 3.13 Billion |
| Compound Annual Growth Rate | 13.1% |
| Regions Covered | Global |
| No. of Companies Mentioned | 15 |
